Adipotide

HGH-Frag (human growth hormone fragment 176–191) is a research peptide used in controlled in-vitro studies of growth-factor–related signalling, energy-metabolism readouts, and peptide structure–activity relationships under non-clinical laboratory conditions.

HGH-Frag (Fragment 176–191)

This C-terminal segment of human growth hormone is selected in model systems to explore assay endpoints linked to receptor-adjacent pathways and peptide pharmacology. All work takes place in laboratory settings only. For laboratory research only. Not for human use.

HGH-Frag Key features

• C-terminal hGH fragment (176–191) for in-vitro signalling and SAR investigations.
• Supplied as a lyophilised solid for stability and straightforward storage.
• Each batch released only after stringent quality checks.

Usage Instructions:

1. Begin by ensuring that your hands are clean and dry.
2. Take the vial of Semaglutide 2mg and inspect it for any signs of damage. Do not use if the seal is broken or compromised.
3. Using a syringe, withdraw the recommended dosage of bacteriostatic water provided with the kit.
4. Inject the bacteriostatic water into the Semaglutide vial, aiming to mix the contents thoroughly. Gently swirl the vial to dissolve the powder until a clear solution is achieved.
5. Once mixed, ensure the solution is free from any particles or discoloration. Do not use if the solution appears cloudy or contains visible particles.
6. Draw the reconstituted Semaglutide solution back into the syringe for administration.

Mixing Guide:

1ml sterile water = 10 x 0.1ml / 200mcg 2ml sterile water = 20 x 0.1ml / 100mcg 1mg = 1000mcg

This product is not: - intended to treat, cure or prevent any disease - a sports supplement - approved for human application - an injectable medicine